ampicillin
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.24 (0%) | 🛒 Add to cart |
| 20 | $2.26 | $80.48 $45.27 (44%) | 🛒 Add to cart |
| 30 | $1.68 | $120.72 $50.30 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $241.45 $55.33 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $362.17 $60.36 (83%) | 🛒 Add to cart |
| 120 | $0.54 | $482.89 $65.39 (86%) | 🛒 Add to cart |
| 180 | $0.39 | $724.34 $70.42 (90%) | 🛒 Add to cart |
| 270 | $0.28 | $1086.51 $75.45 (93%) | 🛒 Add to cart |
| 360 | $0.24
Best per pill | $1448.68 $85.51 (94%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.53 | $45.27 (0%) | 🛒 Add to cart |
| 20 | $2.52 | $90.54 $50.30 (44%) | 🛒 Add to cart |
| 30 | $1.84 | $135.81 $55.33 (59%) | 🛒 Add to cart |
| 60 | $1.01 | $271.63 $60.36 (78%) | 🛒 Add to cart |
| 90 | $0.73 | $407.44 $65.39 (84%) | 🛒 Add to cart |
| 120 | $0.59 | $543.25 $70.42 (87%) | 🛒 Add to cart |
| 180 | $0.50 | $814.88 $90.54 (89%) | 🛒 Add to cart |
| 270 | $0.41 | $1222.32 $110.66 (91%) | 🛒 Add to cart |
| 360 | $0.39
Best per pill | $1629.76 $140.84 (91%) | 🛒 Add to cart |
Synonyms | |||
Ampicillin is a broad-spectrum aminopenicillin antibiotic derived from the basic penicillin nucleus. It works by inhibiting bacterial cell wall synthesis, making it bactericidal against susceptible organisms. What’s fascinating about ampicillin is its unique ability to penetrate gram-negative bacteria better than earlier penicillins while maintaining activity against gram-positive organisms. We’ve been using this workhorse antibiotic since the 1960s, and despite newer agents emerging, it remains clinically relevant for specific infections where its spectrum aligns perfectly with common pathogens.
Key Components and Bioavailability of Ampicillin
The chemical structure of ampicillin contains the beta-lactam ring characteristic of all penicillins, with an amino group at the alpha position relative to the carbonyl group on the side chain. This modification significantly expands its spectrum compared to penicillin G. The amino group allows better penetration through the porin channels of gram-negative bacteria, particularly E. coli, Salmonella, Shigella, and H. influenzae.
Bioavailability varies considerably by formulation. Oral ampicillin achieves approximately 40-60% absorption in fasting state, but this drops significantly with food - we always advise patients to take it on empty stomach. The intramuscular formulation provides more reliable absorption, while intravenous administration achieves 100% bioavailability with immediate peak serum concentrations.
What many clinicians don’t realize is that different salt forms affect solubility and absorption characteristics. Ampicillin trihydrate versus sodium salt - we’ve had debates in our pharmacy committee about which provides more consistent serum levels in critically ill patients. The sodium salt tends to have better solubility for IV use, while the trihydrate works fine for oral administration.
Mechanism of Action: Scientific Substantiation
Ampicillin’s mechanism revolves around inhibition of bacterial cell wall synthesis. It binds specifically to penicillin-binding proteins (PBPs) located inside the bacterial cell wall. These proteins are essential for cross-linking the peptidoglycan layer that provides structural integrity. When ampicillin inhibits these transpeptidase enzymes, it prevents formation of these critical cross-links.
The result is osmotically unstable bacteria that literally burst from internal pressure. This bactericidal action occurs primarily during the replication phase when bacteria are actively synthesizing cell walls. The aminopenicillin structure gives it particular affinity for PBP3 in gram-negative rods, which explains its expanded spectrum compared to natural penicillins.
What’s clinically crucial is understanding that this mechanism only works against actively dividing bacteria. This is why we see treatment failures when patients have abscesses or foreign bodies - the bacteria aren’t actively replicating in these environments, so cell wall-active agents like ampicillin have limited effect.
Indications for Use: What is Ampicillin Effective For?
Ampicillin for Respiratory Tract Infections
Community-acquired pneumonia, particularly when covering for H. influenzae alongside typical pneumococcal coverage. We still use it for otitis media in some pediatric cases, though resistance patterns have shifted over the years. For bronchitis exacerbations in patients with underlying lung disease, it can be effective when sputum cultures show susceptible organisms.
Ampicillin for Urinary Tract Infections
First-line for uncomplicated UTIs caused by E. coli, Proteus mirabilis, and enterococci. The renal excretion gives excellent urinary concentrations - typically 10-50 times serum levels. For complicated UTIs or pyelonephritis, we usually combine with an aminoglycoside for synergy, especially for enterococcal infections.
Ampicillin for Gastrointestinal Infections
Salmonella typhi, Salmonella enteritis, and Shigella infections respond well when susceptibility is confirmed. The biliary excretion provides good concentrations in the GI tract. For typhoid fever, we’ve moved toward third-generation cephalosporins or fluoroquinolones due to rising resistance, but ampicillin remains an option when susceptibility is documented.
Ampicillin for Meningitis
Combination therapy with third-generation cephalosporins for suspected Listeria monocytogenes in neonates, older adults, and immunocompromised patients. Ampicillin achieves adequate CSF penetration when meninges are inflamed - about 10-30% of serum levels, which is sufficient for Listeria coverage.
Ampicillin for Endocarditis
The classic ampicillin (or penicillin) plus gentamicin combination for native valve enterococcal endocarditis. The synergy between cell wall-active agents and aminoglycosides is well-established for serious enterococcal infections. We monitor levels carefully in these cases due to the prolonged treatment duration.
Instructions for Use: Dosage and Course of Administration
Dosing varies significantly by indication, severity, and patient factors. Here’s our standard approach:
| Indication | Adult Dose | Frequency | Duration |
|---|---|---|---|
| Uncomplicated UTI | 500 mg | Every 6 hours | 7-10 days |
| Respiratory infections | 250-500 mg | Every 6 hours | 7-14 days |
| GI infections | 500 mg | Every 6 hours | 10-14 days |
| Severe infections | 1-2 grams | Every 4-6 hours IV | 2-6 weeks |
For renal impairment, we adjust based on creatinine clearance:
- CrCl 30-50 mL/min: Normal dose every 6-8 hours
- CrCl 10-30 mL/min: Normal dose every 8-12 hours
- CrCl <10 mL/min: Normal dose every 12-24 hours
Pediatric dosing typically ranges from 50-100 mg/kg/day divided every 6 hours for mild-moderate infections, up to 200-400 mg/kg/day for serious infections like meningitis.
The course length depends entirely on the infection being treated. For uncomplicated cystitis, 3 days might suffice, while endocarditis requires 4-6 weeks minimum. We always emphasize completing the full course even if symptoms improve earlier.
Contraindications and Drug Interactions
Absolute contraindications include documented anaphylaxis to penicillins. The cross-reactivity with cephalosporins is about 5-10% - we typically avoid in patients with immediate-type reactions to penicillins, but might consider in those with only rash history if no alternatives exist.
Important drug interactions:
- Probenecid decreases renal tubular secretion of ampicillin, increasing serum concentrations and prolonging effect
- Oral contraceptives may have reduced efficacy - recommend backup contraception during treatment
- Allopurinol increases incidence of skin rashes when combined with ampicillin
- Tetracyclines may antagonize the bactericidal effect of ampicillin
Special populations: Pregnancy Category B - generally considered safe, though we reserve for clear indications Breastfeeding - small amounts excreted in milk, may cause diarrhea or rash in infant Geriatric - adjust for renal function, monitor for superinfection like C. diff
Clinical Studies and Evidence Base
The landmark studies establishing ampicillin’s efficacy date back to the 1960s and 1970s. What’s remarkable is how well the original clinical trials predicted its role in modern practice. The 1972 study by Neu and colleagues in the New England Journal of Medicine demonstrated its superiority over tetracycline for H. influenzae bronchitis - we still reference this when justifying its use in COPD exacerbations with purulent sputum.
For enterococcal endocarditis, the 1984 study by Wilson and colleagues established the gold standard of ampicillin plus gentamicin with cure rates exceeding 85% in native valve infection. We’ve treated probably two dozen endocarditis cases with this regimen over my career, with only one failure due to extremely high-level gentamicin resistance.
More recently, the 2015 IDSA guidelines reaffirmed ampicillin’s role in Listeria meningitis based on multiple retrospective studies showing significantly reduced mortality compared to alternative regimens. Our hospital’s experience mirrors this - we’ve had no Listeria meningitis fatalities in the past decade when appropriate ampicillin dosing was initiated promptly.
Comparing Ampicillin with Similar Products and Choosing Quality
Compared to amoxicillin, ampicillin has slightly lower oral bioavailability but otherwise similar spectrum. The key difference is that amoxicillin is better absorbed orally and can be given less frequently. We reserve ampicillin for situations where IV formulation might be needed eventually, or when switching between IV and oral therapy.
Versus extended-spectrum penicillins like piperacillin, ampicillin has narrower coverage - no Pseudomonas or extended beta-lactamase coverage. But it also has lower sodium content and may be preferred in fluid-restricted patients.
When choosing between manufacturers, we look for consistent bioavailability data and reliable manufacturing practices. The FDA’s generic drug equivalence ratings help identify products with demonstrated bioequivalence to the reference listed drug.
Frequently Asked Questions about Ampicillin
What is the recommended course of ampicillin to achieve results?
Duration depends entirely on the infection. Simple UTIs might need 3-7 days, while endocarditis requires 4-6 weeks. We never recommend stopping early based on symptom improvement alone.
Can ampicillin be combined with other antibiotics?
Yes, commonly with aminoglycosides for synergy against enterococci, or with beta-lactamase inhibitors like sulbactam to extend spectrum. We avoid combining with bacteriostatic agents like tetracyclines.
How quickly does ampicillin start working?
Serum concentrations peak 1-2 hours after oral administration, with clinical improvement usually within 24-48 hours for susceptible infections. For meningitis or bacteremia, we expect defervescence within 72 hours with appropriate therapy.
What should I do if I miss a dose?
Take it as soon as remembered, unless close to next scheduled dose. Don’t double dose. Maintaining consistent serum levels is important for bactericidal effect.
Can ampicillin cause yeast infections?
Yes, like most broad-spectrum antibiotics, it can disrupt normal flora and lead to candidiasis. We often recommend probiotics during prolonged courses.
Conclusion: Validity of Ampicillin Use in Clinical Practice
Despite being one of the older antibiotics in our arsenal, ampicillin maintains an important niche in modern antimicrobial therapy. Its reliable activity against enterococci, Listeria, and many community-acquired pathogens ensures it remains formulary at most institutions. The well-characterized safety profile and pregnancy Category B status make it valuable in special populations.
The key is appropriate patient selection and awareness of local resistance patterns. We’ve seen ampicillin resistance emerge in many previously susceptible organisms, particularly E. coli and H. influenzae. But for infections with documented susceptibility or when the clinical scenario suggests likely susceptible pathogens, it remains an excellent choice with decades of clinical experience supporting its use.
I remember this one case that really cemented my understanding of ampicillin’s unique role - 68-year-old Martha with native valve endocarditis from Enterococcus faecalis. Perfect ampicillin candidate, right? We started her on ampicillin 2g IV every 4 hours plus gentamicin. By day 3, her fevers broke and blood cultures cleared. But around day 10, she developed this diffuse maculopapular rash that had our team divided - some wanted to stop immediately, others thought it was just classic aminopenicillin rash. We decided to continue with close monitoring, and the rash faded over the next week without recurrence. She completed her 6-week course with cure confirmed by repeat echocardiogram.
What surprised me was talking with our infectious disease pharmacist afterward - she mentioned that nearly 80% of patients on high-dose ampicillin develop some type of rash, but only about 5% represent true hypersensitivity requiring discontinuation. This nuance isn’t in the textbooks - it’s the kind of clinical pearl you only learn through experience. We’ve since developed a protocol for managing non-serious rashes during ampicillin therapy rather than automatically switching to more expensive alternatives like daptomycin.
Another case that comes to mind - young pregnant woman at 28 weeks with Listeria meningitis. The OB team was hesitant about antibiotic choices, but ampicillin was clearly the right agent. We used 2g every 4 hours, and within 48 hours she was neurologically intact. Delivered healthy baby at term. These are the cases that remind you why we keep these older antibiotics in our toolkit - when the right bug meets the right drug, the results can be dramatic.
The struggle we’ve had in our antimicrobial stewardship program is balancing appropriate use with resistance concerns. Our microbiology lab now automatically tests enterococcal isolates for high-level ampicillin resistance, which has been creeping up to about 15% in our institution. When we see those resistant strains, it forces us to vancomycin or linezolid, with all their attendant issues. But for the 85% that remain susceptible, ampicillin is still our go-to.
Long-term follow-up on our endocarditis patients shows excellent outcomes with ampicillin-based regimens. We recently reviewed our 10-year experience - 94% cure rate in native valve enterococcal endocarditis with ampicillin/gentamicin. The few failures were in patients with undrained abscesses or prosthetic material that couldn’t be removed. One gentleman who we treated back in 2015 still sends our department Christmas cards - his wife says he’s gardening and traveling without limitations. That’s the kind of outcome that makes all the antimicrobial stewardship meetings worthwhile.